Determine the necessary mass, volume, or concentration for preparing a solution.
≥99% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.
Appearance:Solid
IC50& Target:TrkA
In Vitro:TrkA-IN-4 (compound 39) demonstrates 65.1% and 46.3% of kinase inhibition towards TrkA at concentrations of 1 μM and 0.1 μM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo:TrkA-IN-4 (compound 39) (0.9375-120mg/kg; i.g.) exhibits stronger maximum antinociceptive effects 3 h after administration, with an ED 50 of 7.836mg/kg in hot plate testing on male mice. MCE has not independently confirmed the accuracy of these met
Biological Activity:TrkA-IN-4, a potent, orally active and allosteric TrkA inhibitor, is a proagent of TrkA-IN-3 ( HY-151948 ). TrkA-IN-4 exhibits potent antinociceptive effects.
| Canonical Smiles | CC(OCOC(C1=CN=C(C(NC(C2=CC=C(C(C3=NN(C=C3)C)=C2)C(F)(F)F)=O)=C1)C4=CC=CC=C4)=O)=O |
|---|---|
| Molecular Weight | 538.47 |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Solubility | DMSO : 50 mg/mL (92.86 mM; ultrasonic and warming and heat to 60°C) |
|---|